TR200000958T2 - Hiperglisemi tedavisinde tiazolidinedion kullanımı. - Google Patents

Hiperglisemi tedavisinde tiazolidinedion kullanımı.

Info

Publication number
TR200000958T2
TR200000958T2 TR2000/00958T TR200000958T TR200000958T2 TR 200000958 T2 TR200000958 T2 TR 200000958T2 TR 2000/00958 T TR2000/00958 T TR 2000/00958T TR 200000958 T TR200000958 T TR 200000958T TR 200000958 T2 TR200000958 T2 TR 200000958T2
Authority
TR
Turkey
Prior art keywords
hyperglycemia
thiazolidinedione
treatment
mammal
toxic
Prior art date
Application number
TR2000/00958T
Other languages
English (en)
Turkish (tr)
Inventor
Edwin Buckingham Robin
Alistair Smith Stephan
Original Assignee
Smithkline Beecham P.L.C.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham P.L.C. filed Critical Smithkline Beecham P.L.C.
Publication of TR200000958T2 publication Critical patent/TR200000958T2/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
TR2000/00958T 1997-10-13 1998-10-12 Hiperglisemi tedavisinde tiazolidinedion kullanımı. TR200000958T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9721693.1A GB9721693D0 (en) 1997-10-13 1997-10-13 Novel treatment

Publications (1)

Publication Number Publication Date
TR200000958T2 true TR200000958T2 (tr) 2000-08-21

Family

ID=10820482

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2000/00958T TR200000958T2 (tr) 1997-10-13 1998-10-12 Hiperglisemi tedavisinde tiazolidinedion kullanımı.

Country Status (24)

Country Link
EP (1) EP1023056A1 (fr)
JP (1) JP2001519382A (fr)
KR (1) KR20010024481A (fr)
CN (1) CN1281359A (fr)
AP (1) AP2000001787A0 (fr)
AU (1) AU9547098A (fr)
BG (1) BG104404A (fr)
BR (1) BR9815219A (fr)
CA (1) CA2306086A1 (fr)
CZ (1) CZ20001297A3 (fr)
EA (1) EA002659B1 (fr)
GB (1) GB9721693D0 (fr)
HR (1) HRP20000255A2 (fr)
HU (1) HUP0003922A3 (fr)
ID (1) ID24521A (fr)
IL (1) IL135513A0 (fr)
NO (1) NO20001898L (fr)
NZ (1) NZ503862A (fr)
OA (1) OA11683A (fr)
PL (1) PL339813A1 (fr)
SK (1) SK5312000A3 (fr)
TR (1) TR200000958T2 (fr)
WO (1) WO1999018943A1 (fr)
YU (1) YU28800A (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7045519B2 (en) 1998-06-19 2006-05-16 Chiron Corporation Inhibitors of glycogen synthase kinase 3

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE186724T1 (de) * 1987-09-04 1999-12-15 Beecham Group Plc Substituierte thiazolidindionderivate
GB9218830D0 (en) * 1992-09-05 1992-10-21 Smithkline Beecham Plc Novel compounds
US5457109A (en) * 1993-09-15 1995-10-10 Warner-Lambert Company Use of thiazolidinedione derivatives and related antihyperglycemic agents in the treatment of disease states at risk for progressing to noninsulin-dependent diabetes mellitus

Also Published As

Publication number Publication date
NZ503862A (en) 2003-01-31
KR20010024481A (ko) 2001-03-26
SK5312000A3 (en) 2000-09-12
PL339813A1 (en) 2001-01-02
JP2001519382A (ja) 2001-10-23
CZ20001297A3 (cs) 2001-08-15
WO1999018943A1 (fr) 1999-04-22
EP1023056A1 (fr) 2000-08-02
GB9721693D0 (en) 1997-12-10
CA2306086A1 (fr) 1999-04-22
BR9815219A (pt) 2001-01-02
EA200000419A1 (ru) 2000-10-30
CN1281359A (zh) 2001-01-24
EA002659B1 (ru) 2002-08-29
NO20001898D0 (no) 2000-04-12
HUP0003922A3 (en) 2001-12-28
OA11683A (en) 2005-01-12
AU9547098A (en) 1999-05-03
HRP20000255A2 (en) 2001-02-28
HUP0003922A2 (hu) 2001-10-28
AP2000001787A0 (en) 2000-06-30
NO20001898L (no) 2000-06-09
BG104404A (bg) 2000-12-29
IL135513A0 (en) 2001-05-20
YU28800A (sh) 2003-02-28
ID24521A (id) 2000-07-20

Similar Documents

Publication Publication Date Title
SG127714A1 (en) Method of treating metabolic disorders, especiallydiabetes, or a disease or condition associated wi th diabetes
EA200101089A1 (ru) Новый способ лечения
DK1373215T3 (da) Gelanamycinderivater egnet til behandling af cancer
EA200300026A1 (ru) Аналоги глюкагоноподобного пептида-1
TR199903057T2 (xx) Diabetin tiazolidinedion ve metformin ile tedavisi.
PT1333887E (pt) Metodo de tratamento de desordens musculares
MXPA04001525A (es) Analogos de peptido -1 similar al glucagon.
TR200101174T2 (tr) Migren tedavisi için 5HT1, reseptör agonistleri ve metoklopramid.
CA2071629A1 (fr) Utilisation de substances sensibilisantes a l'insuline pour le traitement de l'hypertension
IL143569A0 (en) A combination of fbpase inhibitors and insulin sensitizers for the treatment of diabetes
ES2178675T3 (es) Agente estimulante del tejido duro.
BR0311161A (pt) Método de tratamento de diabetes
NO20083276L (no) Behandling av diabetes med tiazolidindion og sulfonylurea
MY155219A (en) Treatment of diabetes with thiazolidinedione, insulin secretagogue and biguanide
CY1107745T1 (el) Αγωγη του διαβητη με θειαζολιδινοδιονη και σουλφονυλουρια
TR199903095T2 (xx) Diabetin roziglitazon ve ins�lin ile tedavisi.
HK1042852A1 (zh) 增强胰岛素反应的方法
NO996270L (no) Behandling av diabetes med tiazolidindion og <alfa>- glukosidaseinhibitor
AP2000001735A0 (en) Treatment of diabetes with thiazolidinedione insulin secretagogue and alpha glucocidase inhibitor.
TR200101336T2 (tr) Bir-beta-agonisti ile başka bir antidiyabetik madde içeren kombinasyonlar
TR200000957T2 (tr) Hiperglisemi tedavisinde tiazolidinedion kullanımı
NO20003813L (no) FremgangsmÕter for Õ redusere eller forhindre smerte ved bruk av spicamycin eller derivater derav
TR200202033T2 (tr) Epilepsi Tedavisi İçin Terkipler ve Yöntemler
AP2000001787A0 (en) Use of thiazolidinediones for the treatment of hyperglycaemia.
AU4193800A (en) Use of tagatose to enhance key blood factors